Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 2,077.20
-39.10 (-1.85%)
Oct 1, 2026, 3:30 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 338.62 billion as of October 1, 2026. Its market cap has increased by 37.46% in one year.
Market Cap
338.62B
Enterprise Value
358.22B
Revenue
36.53B
Ranking
n/a
PE Ratio
82.74
Stock Price
2,077.20
ChartMarket Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 338.62B, an increase of 1,845.65%. That is a compound annual growth rate of 12.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 338.62B | 44.09% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 656.31B |
| Alkem Laboratories | 618.75B |
| Ipca Laboratories | 486.93B |
| Gland Pharma | 477.74B |
| Ajanta Pharma | 440.42B |
| Emcure Pharmaceuticals | 371.60B |
| Piramal Pharma | 274.61B |
| Cohance Lifesciences | 173.42B |